United States Veterinary Drugs Market Report 2016

December 2016 | 96 pages | ID: U73B679280BEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Veterinary Drugs

Revenue, means the sales value of Veterinary Drugs

This report studies sales (consumption) of Veterinary Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Zoetis(Pfizer)
• MERIAL
• Merial
• Lilly
• Bayer
• Boehringer
• Novartis
• Virbac
• Ceva
• Vetoquinol

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Veterinary biological drugs
• Veterinary preparations
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Veterinary Drugs in each application, can be divided into

• Poultry
• Ruminants
• Pigs
• Pets
• Others

Contents

United States Veterinary Drugs Market Report 2016

1 VETERINARY DRUGS OVERVIEW

1.1 Product Overview and Scope of Veterinary Drugs
1.2 Classification of Veterinary Drugs
  1.2.1 Veterinary biological drugs
  1.2.2 Veterinary preparations
  1.2.3 Type III
1.3 Application of Veterinary Drugs
  1.3.1 Poultry
  1.3.2 Ruminants
  1.3.3 Pigs
  1.3.4 Pets
  1.3.5 Others
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Veterinary Drugs (2011-2021)
  1.4.1 United States Veterinary Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Veterinary Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES VETERINARY DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Veterinary Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Veterinary Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Veterinary Drugs Average Price by Manufactures (2015 and 2016)
2.4 Veterinary Drugs Market Competitive Situation and Trends
  2.4.1 Veterinary Drugs Market Concentration Rate
  2.4.2 Veterinary Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES VETERINARY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Veterinary Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Veterinary Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Veterinary Drugs Price by Type (2011-2016)
3.4 United States Veterinary Drugs Sales Growth Rate by Type (2011-2016)

4 UNITED STATES VETERINARY DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Veterinary Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Veterinary Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES VETERINARY DRUGS MANUFACTURERS PROFILES/ANALYSIS

5.1 Zoetis(Pfizer)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Veterinary Drugs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Zoetis(Pfizer) Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 MERIAL
  5.2.2 Veterinary Drugs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 MERIAL Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Merial
  5.3.2 Veterinary Drugs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Merial Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Lilly
  5.4.2 Veterinary Drugs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Lilly Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Bayer
  5.5.2 Veterinary Drugs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Bayer Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Boehringer
  5.6.2 Veterinary Drugs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Boehringer Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Novartis
  5.7.2 Veterinary Drugs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Novartis Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Virbac
  5.8.2 Veterinary Drugs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Virbac Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Ceva
  5.9.2 Veterinary Drugs Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Ceva Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Vetoquinol
  5.10.2 Veterinary Drugs Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Vetoquinol Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 VETERINARY DRUGS MANUFACTURING COST ANALYSIS

6.1 Veterinary Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Veterinary Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Veterinary Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Veterinary Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES VETERINARY DRUGS MARKET FORECAST (2016-2021)

10.1 United States Veterinary Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Veterinary Drugs Sales Forecast by Type (2016-2021)
10.3 United States Veterinary Drugs Sales Forecast by Application (2016-2021)
10.4 Veterinary Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Veterinary Drugs
Table Classification of Veterinary Drugs
Figure United States Sales Market Share of Veterinary Drugs by Type in 2015
Figure Veterinary biological drugs Picture
Figure Veterinary preparations Picture
Table Application of Veterinary Drugs
Figure United States Sales Market Share of Veterinary Drugs by Application in 2015
Figure Poultry Examples
Figure Ruminants Examples
Figure Pigs Examples
Figure Pets Examples
Figure Others Examples
Figure United States Veterinary Drugs Sales and Growth Rate (2011-2021)
Figure United States Veterinary Drugs Revenue and Growth Rate (2011-2021)
Table United States Veterinary Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Veterinary Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Veterinary Drugs Sales Share by Manufacturers
Figure 2016 Veterinary Drugs Sales Share by Manufacturers
Table United States Veterinary Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Veterinary Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Veterinary Drugs Revenue Share by Manufacturers
Table 2016 United States Veterinary Drugs Revenue Share by Manufacturers
Table United States Market Veterinary Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Veterinary Drugs Average Price of Key Manufacturers in 2015
Figure Veterinary Drugs Market Share of Top 3 Manufacturers
Figure Veterinary Drugs Market Share of Top 5 Manufacturers
Table United States Veterinary Drugs Sales by Type (2011-2016)
Table United States Veterinary Drugs Sales Share by Type (2011-2016)
Figure United States Veterinary Drugs Sales Market Share by Type in 2015
Table United States Veterinary Drugs Revenue and Market Share by Type (2011-2016)
Table United States Veterinary Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Veterinary Drugs by Type (2011-2016)
Table United States Veterinary Drugs Price by Type (2011-2016)
Figure United States Veterinary Drugs Sales Growth Rate by Type (2011-2016)
Table United States Veterinary Drugs Sales by Application (2011-2016)
Table United States Veterinary Drugs Sales Market Share by Application (2011-2016)
Figure United States Veterinary Drugs Sales Market Share by Application in 2015
Table United States Veterinary Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Veterinary Drugs Sales Growth Rate by Application (2011-2016)
Table Zoetis(Pfizer) Basic Information List
Table Zoetis(Pfizer) Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Zoetis(Pfizer) Veterinary Drugs Sales Market Share (2011-2016)
Table MERIAL Basic Information List
Table MERIAL Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table MERIAL Veterinary Drugs Sales Market Share (2011-2016)
Table Merial Basic Information List
Table Merial Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merial Veterinary Drugs Sales Market Share (2011-2016)
Table Lilly Basic Information List
Table Lilly Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lilly Veterinary Drugs Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Veterinary Drugs Sales Market Share (2011-2016)
Table Boehringer Basic Information List
Table Boehringer Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Veterinary Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Veterinary Drugs Sales Market Share (2011-2016)
Table Virbac Basic Information List
Table Virbac Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Virbac Veterinary Drugs Sales Market Share (2011-2016)
Table Ceva Basic Information List
Table Ceva Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ceva Veterinary Drugs Sales Market Share (2011-2016)
Table Vetoquinol Basic Information List
Table Vetoquinol Veterinary Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vetoquinol Veterinary Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Veterinary Drugs
Figure Manufacturing Process Analysis of Veterinary Drugs
Figure Veterinary Drugs Industrial Chain Analysis
Table Raw Materials Sources of Veterinary Drugs Major Manufacturers in 2015
Table Major Buyers of Veterinary Drugs
Table Distributors/Traders List
Figure United States Veterinary Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Veterinary Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Veterinary Drugs Production Forecast by Type (2016-2021)
Table United States Veterinary Drugs Consumption Forecast by Application (2016-2021)